CRBC News

Judge Signals Approval of $7 Billion Purdue Pharma Settlement with Sackler Family, Victims to Receive Payments

A New York judge has indicated he will approve a roughly $7 billion settlement between Purdue Pharma and the Sackler family. The agreement includes designated payments to compensate victims and support communities affected by the opioid crisis. This development advances a long-running effort to resolve lawsuits tied to the company’s role in the epidemic. Final implementation still depends on formal court approval and any remaining procedural steps.

New York Judge Indicates He Will Approve $7 Billion Purdue Pharma Settlement

A New York judge has said he will approve a roughly $7 billion settlement between Purdue Pharma and members of the Sackler family that includes designated payments for victims of the U.S. opioid crisis.

The proposed agreement is a major step in long-running litigation over Purdue's role in the opioid epidemic. Under the settlement terms, funds would be allocated to help communities and individuals affected by opioid addiction and overdoses, providing compensation and resources for remediation efforts.

The judge's announcement moves the settlement closer to implementation, though finalization still depends on formal court approval and remaining procedural steps.

Legal experts say the deal would resolve a large portion of claims against the company and members of the Sackler family, bringing long-sought financial relief to many plaintiffs while closing a contentious chapter in one of the nation’s largest public-health lawsuits.

Next steps: The court will issue a formal order to approve the settlement before funds can begin to be distributed. Until that order is entered and any appeals are resolved, the plan remains subject to change.